Greetings from the President


wataru shimizu 2021

Dear Colleagues,

I am pleased to announce that I have been appointed to serve a second one-year term as President of the APHRS, beginning in January 2023, and I am once again humbled by the weight of this responsibility. 

Thanks to the efforts of past presidents, board members, and members, the APHRS has made great strides since its establishment in 2008. Arrhythmia is one of the three major areas of cardiovascular disease along with ischemic heart disease and heart failure. Modern arrhythmia treatment consists of a wide variety of areas, including non-pharmacological treatment such as catheter ablation, arrhythmia device therapy (ICD, CRT, remote monitoring) and arrhythmia surgery, pharmacological treatment including anticoagulation therapy, genetic diagnosis of hereditary arrhythmia, and recently the prediction and diagnosis of arrhythmia using digital technology such as artificial intelligence (AI), wearable devices, and big data analysis.

On the other hand, the Asia Pacific region is a very diverse region in terms of race, economy, and medical and academic levels. For this reason, one of the important missions of the APHRS is to ensure the equalization of the level of medical care in the Asia Pacific region. One of the key elements necessary to achieve this is to provide extensive education for members involved in arrhythmia care in the region. Arrhythmia treatment, especially ablation and arrhythmia device therapy, often involves the use of highly advanced medical devices, and it is important to have a multidisciplinary team approach with the participation of medical professionals (clinical engineers, clinical technologists, nurses, radiology technologists, pharmacists, and CDRs). Due to the spread of the COVID-19 infection since the beginning of 2020, we have been delivering online educational programs for the past two years.

A face-to-face APHRS 2022 could be held in Singapore last November for the first time in three years. We were able to have an enthusiastic discussion at the face-to-face conference that everyone had been looking forward to. We will continue to promote education by holding face-to-face conferences and educational programs, while taking all possible measures to prevent infections. APHRS is also an Asia Pacific regional society that exists as a counterpart to North America (HRS), Europe (EHRA), and Latin America (LAHRS). To this end, we would like to strengthen our cooperation with HRS, EHRA, LAHRS, and other societies representing the region more than ever, organize joint sessions and publish Consensus Statements. Furthermore, the development of research and practice in the Asia Pacific region also requires the creation of a reliable database for catheter ablation and arrhythmia device therapy. I believe it is necessary to promote registration studies and document writings that take advantage of the characteristics of the Asia Pacific region. In order to further develop the APHRS on an ongoing basis, it is necessary to foster young physicians who aspire to become arrhythmia specialists, actively involve female physicians, and promote exchange between basic medical scientists and clinicians, which I will actively promote.

As President of the APHRS, I will do my utmost to address these issues, more than ever before, and I look forward to your support and encouragement with our board members and members.

Wataru Shimizu, MD, FAPHRS
President of the APHRS (2023)

Join Our Membership

Become a member and gain free access to all member benefits.

Join Now



Don't have an account yet? Sign up now.
Reset password